Correlation Between Pmv Pharmaceuticals and Imunon
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Imunon Inc, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Imunon.
Diversification Opportunities for Pmv Pharmaceuticals and Imunon
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pmv and Imunon is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Imunon go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Imunon
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.43 times more return on investment than Imunon. However, Pmv Pharmaceuticals is 2.32 times less risky than Imunon. It trades about 0.0 of its potential returns per unit of risk. Imunon Inc is currently generating about -0.06 per unit of risk. If you would invest 163.00 in Pmv Pharmaceuticals on September 1, 2024 and sell it today you would lose (1.00) from holding Pmv Pharmaceuticals or give up 0.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Imunon Inc
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Imunon Inc |
Pmv Pharmaceuticals and Imunon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Imunon
The main advantage of trading using opposite Pmv Pharmaceuticals and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.| Pmv Pharmaceuticals vs. Tff Pharmaceuticals | Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. Inhibrx | Pmv Pharmaceuticals vs. Enliven Therapeutics |
| Imunon vs. Exicure | Imunon vs. Cyclacel Pharmaceuticals | Imunon vs. Histogen | Imunon vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |